China NMPA Drug Inspection - Jining Vasculitis Hospital - Yiqi Tongmai Capsules
China NMPA drug inspection for Jining Vasculitis Hospital published February 09, 2018. Drug: Yiqi Tongmai Capsules. The Shandong Provincial Food and Drug Administration announced on February 9, 2018, the findings of sampling inspections
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Jining Vasculitis Hospital published February 09, 2018. Drug: Yiqi Tongmai Capsules. The Shandong Provincial Food and Drug Administration announced on February 9, 2018, the findings of sampling inspections
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Jining Vasculitis HospitalInspection Date
Unknown Date
Product Type
ID: 95212222-2104-4ccf-9efc-128cdf428990
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox